Neurological complications of the human immunodeficiency virus (HIV) infection

被引:0
作者
Garcia-Monco, J. C. [1 ]
Brochado, A. Pinedo [1 ]
Cortina, I. Escalza [1 ]
机构
[1] Hosp Galdacano, Serv Neurol, Galdakao 48960, Vizcaya, Spain
来源
NEUROLOGIA | 2007年 / 22卷 / 05期
关键词
human immunodeficiency virus; acquired immunodeficiency syndrome; CD4; lymphocytes; neurological complications;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Human immunodeficiency virus infection (HIV) is entering into its third decade affecting more than 40 million persons on the plane, with an extraordinary incidence in the underdeveloped world, especially in the African continen where more than 25 million are affected, with more than 3 million new yearly infections and where the life expectancy is at 47 years. Although the vaccination is still far away, the introduction of combined antiretroviral therapy in the middle of the 90's was an important advance that contributed to converting an infection that previously had a very high rate of short-term mortality into a chronic disease. The neurological complications of this infection vary enormously. They affect any location of the neuroaxis and can appear at any stage of infection. It is not rare that more than one neurological complication exists. Such complications may be a consequence of the infection itself (primary) or related with immune depression accompanying it (secondary). Among the former, dementia associated to HIV and peripheral polyneuropathy stant out. Among the latter, opportunistic viral and fungal infections and lymphoma of the nervous systems stand out. In recent years different tests that help to establish the diagnoses of these entities have been developed, a necessary step to initiate adequate therapies. The immune state of the patient, reflected by the peripheral count of CD4 lymphocytes and serum viral load, helps us to establish the most likely causes of the neurological problems that appear in the context of this infection. We briefly review the most outstanding characteristics of each one of them in this work.
引用
收藏
页码:312 / 319
页数:8
相关论文
共 37 条
[1]   Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy [J].
Antinori, A ;
Larussa, D ;
Cingolani, A ;
Lorenzini, P ;
Bossolasco, S ;
Finazzi, MG ;
Bongiovanni, M ;
Guaraldi, G ;
Grisetti, S ;
Vigo, B ;
Gigli, B ;
Mariano, A ;
Dalle Nogare, ER ;
De Marco, M ;
Moretti, F ;
Corsi, P ;
Abrescia, N ;
Rellecati, P ;
Castagna, A ;
Mussini, C ;
Ammassari, A ;
Cinque, P ;
Monforte, AD .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (11) :1681-1691
[2]  
Antinori A, 1999, ANN NEUROL, V45, P259
[3]   T-cell responses to Treponema pallidum subsp pallidum antigens during the course of experimental syphilis infection [J].
Arroll, TW ;
Centurion-Lara, A ;
Lukehart, SA ;
Van Voorhis, WC .
INFECTION AND IMMUNITY, 1999, 67 (09) :4757-4763
[4]   Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma [J].
Bossolasco, S ;
Cinque, P ;
Ponzoni, M ;
Vigano, MG ;
Lazzarin, A ;
Linde, A ;
Falk, KI .
JOURNAL OF NEUROVIROLOGY, 2002, 8 (05) :432-438
[5]   The peripheral nerve complications of human immunodeficiency virus (HIV) infection [J].
Brew, BJ .
MUSCLE & NERVE, 2003, 28 (05) :542-552
[6]  
Cinque P, 2000, J NEUROVIROL, V6, pS95
[7]   Diagnosis of central nervous system complications in HIV-infected patients: Cerebrospinal fluid analysis by the polymerase chain reaction [J].
Cinque, P ;
Scarpellini, P ;
Vago, L ;
Linde, A ;
Lazzarin, A .
AIDS, 1997, 11 (01) :1-17
[8]   GANCICLOVIR THERAPY FOR CYTOMEGALOVIRUS (CMV) INFECTION OF THE CENTRAL-NERVOUS-SYSTEM IN AIDS PATIENTS - MONITORING BY CMV DNA DETECTION IN CEREBROSPINAL-FLUID [J].
CINQUE, P ;
BALDANTI, F ;
VAGO, L ;
TERRENI, MR ;
LILLO, F ;
FURIONE, M ;
CASTAGNA, A ;
MONFORTE, AD ;
LAZZARIN, A ;
LINDE, A .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (06) :1603-1606
[9]  
CLIFFORD DB, 2006, NEUROLOGICAL THERAPE, P1060
[10]   Variable benefit in neuropsychological function in HIV-infected HAART-treated patients [J].
Cysique, LAJ ;
Maruff, P ;
Brew, BJ .
NEUROLOGY, 2006, 66 (09) :1447-1450